‘Game-changing’ Weight-Loss Jab, Wegovy, Experiences Unforeseen Overwhelming Demand, Leading to Indefinite Delay of £40 Million Pilot Scheme
The Government’s £40 million pilot scheme, a key component of their anti-obesity strategy, has been postponed due to a significant shortage of weight-loss jabs. In an effort to enhance the health of thousands of patients and reduce hospital waiting lists, GPs were set to provide semaglutide under the brand name Wegovy. However, the overwhelming global …